Project
Illumina Body Map 2
Navigation
Downloads
Results for FOXM1_TBL1XR1
Z-value: 3.02
Motif logo
Transcription factors associated with FOXM1_TBL1XR1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
FOXM1
|
ENSG00000111206.8 | forkhead box M1 |
|
TBL1XR1
|
ENSG00000177565.11 | TBL1X receptor 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| FOXM1 | hg19_v2_chr12_-_2986107_2986258 | 0.44 | 1.2e-02 | Click! |
| TBL1XR1 | hg19_v2_chr3_-_176914998_176915021 | -0.11 | 5.6e-01 | Click! |
Activity profile of FOXM1_TBL1XR1 motif
Sorted Z-values of FOXM1_TBL1XR1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr14_+_22748980 | 13.14 |
ENST00000390465.2
|
TRAV38-2DV8
|
T cell receptor alpha variable 38-2/delta variable 8 |
| chr1_+_117297007 | 10.65 |
ENST00000369478.3
ENST00000369477.1 |
CD2
|
CD2 molecule |
| chr2_+_102608306 | 10.52 |
ENST00000332549.3
|
IL1R2
|
interleukin 1 receptor, type II |
| chr1_-_169680745 | 9.37 |
ENST00000236147.4
|
SELL
|
selectin L |
| chr7_+_37888199 | 9.31 |
ENST00000199447.4
ENST00000455500.1 |
NME8
|
NME/NM23 family member 8 |
| chr7_+_142045246 | 8.81 |
ENST00000390392.3
|
TRBV4-2
|
T cell receptor beta variable 4-2 |
| chr14_+_22771851 | 8.74 |
ENST00000390466.1
|
TRAV39
|
T cell receptor alpha variable 39 |
| chr14_+_22520762 | 8.57 |
ENST00000390449.3
|
TRAV21
|
T cell receptor alpha variable 21 |
| chr14_+_22739823 | 8.43 |
ENST00000390464.2
|
TRAV38-1
|
T cell receptor alpha variable 38-1 |
| chr14_+_22689792 | 8.42 |
ENST00000390462.1
|
TRAV35
|
T cell receptor alpha variable 35 |
| chr7_-_142198049 | 8.39 |
ENST00000471935.1
|
TRBV11-2
|
T cell receptor beta variable 11-2 |
| chr22_+_22723969 | 8.28 |
ENST00000390295.2
|
IGLV7-46
|
immunoglobulin lambda variable 7-46 (gene/pseudogene) |
| chr14_-_106967788 | 8.06 |
ENST00000390622.2
|
IGHV1-46
|
immunoglobulin heavy variable 1-46 |
| chr4_-_74847800 | 8.00 |
ENST00000296029.3
|
PF4
|
platelet factor 4 |
| chr7_+_142012967 | 7.99 |
ENST00000390357.3
|
TRBV4-1
|
T cell receptor beta variable 4-1 |
| chr22_+_22749343 | 7.54 |
ENST00000390298.2
|
IGLV7-43
|
immunoglobulin lambda variable 7-43 |
| chr14_+_22191940 | 7.44 |
ENST00000390425.2
|
TRAV3
|
T cell receptor alpha variable 3 (gene/pseudogene) |
| chrX_-_70329118 | 7.28 |
ENST00000374188.3
|
IL2RG
|
interleukin 2 receptor, gamma |
| chr7_+_142031986 | 7.27 |
ENST00000547918.2
|
TRBV7-1
|
T cell receptor beta variable 7-1 (non-functional) |
| chr5_+_54398463 | 7.12 |
ENST00000274306.6
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) |
| chr2_+_87565634 | 7.01 |
ENST00000421835.2
|
IGKV3OR2-268
|
immunoglobulin kappa variable 3/OR2-268 (non-functional) |
| chr2_-_90538397 | 6.85 |
ENST00000443397.3
|
RP11-685N3.1
|
Uncharacterized protein |
| chr12_-_10151773 | 6.81 |
ENST00000298527.6
ENST00000348658.4 |
CLEC1B
|
C-type lectin domain family 1, member B |
| chr2_-_89160117 | 6.68 |
ENST00000390238.2
|
IGKJ5
|
immunoglobulin kappa joining 5 |
| chr22_+_23222886 | 6.67 |
ENST00000390319.2
|
IGLV3-1
|
immunoglobulin lambda variable 3-1 |
| chr7_-_142131914 | 6.62 |
ENST00000390375.2
|
TRBV5-6
|
T cell receptor beta variable 5-6 |
| chr19_+_51645556 | 6.60 |
ENST00000601682.1
ENST00000317643.6 ENST00000305628.7 ENST00000600577.1 |
SIGLEC7
|
sialic acid binding Ig-like lectin 7 |
| chr14_+_22931924 | 6.56 |
ENST00000390477.2
|
TRDC
|
T cell receptor delta constant |
| chr14_+_22446680 | 6.53 |
ENST00000390443.3
|
TRAV8-6
|
T cell receptor alpha variable 8-6 |
| chr14_+_22337014 | 6.47 |
ENST00000390436.2
|
TRAV13-1
|
T cell receptor alpha variable 13-1 |
| chr12_-_10541575 | 6.46 |
ENST00000540818.1
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1 |
| chr15_-_22448819 | 6.44 |
ENST00000604066.1
|
IGHV1OR15-1
|
immunoglobulin heavy variable 1/OR15-1 (non-functional) |
| chr19_-_54824344 | 6.40 |
ENST00000346508.3
ENST00000446712.3 ENST00000432233.3 ENST00000301219.3 |
LILRA5
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 |
| chr19_+_42381173 | 6.38 |
ENST00000221972.3
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
| chr1_+_158259558 | 6.36 |
ENST00000368170.3
|
CD1C
|
CD1c molecule |
| chr22_+_23063100 | 6.33 |
ENST00000390309.2
|
IGLV3-19
|
immunoglobulin lambda variable 3-19 |
| chr1_-_25291475 | 6.30 |
ENST00000338888.3
ENST00000399916.1 |
RUNX3
|
runt-related transcription factor 3 |
| chr7_+_142000747 | 6.25 |
ENST00000455382.2
|
TRBV2
|
T cell receptor beta variable 2 |
| chr16_+_30483962 | 6.25 |
ENST00000356798.6
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
| chr2_+_89975669 | 6.18 |
ENST00000474213.1
|
IGKV2D-30
|
immunoglobulin kappa variable 2D-30 |
| chr19_-_7766991 | 6.08 |
ENST00000597921.1
ENST00000346664.5 |
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23) |
| chr16_+_30484021 | 5.92 |
ENST00000358164.5
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
| chr14_+_22580233 | 5.86 |
ENST00000390454.2
|
TRAV25
|
T cell receptor alpha variable 25 |
| chr1_+_160709055 | 5.84 |
ENST00000368043.3
ENST00000368042.3 ENST00000458602.2 ENST00000458104.2 |
SLAMF7
|
SLAM family member 7 |
| chr2_-_89278535 | 5.83 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
| chr11_+_60163918 | 5.73 |
ENST00000526375.1
ENST00000531783.1 ENST00000395001.1 |
MS4A14
|
membrane-spanning 4-domains, subfamily A, member 14 |
| chr6_-_25042390 | 5.72 |
ENST00000606385.1
|
RP11-367G6.3
|
RP11-367G6.3 |
| chr6_+_31540056 | 5.69 |
ENST00000418386.2
|
LTA
|
lymphotoxin alpha |
| chrX_-_55057403 | 5.68 |
ENST00000396198.3
ENST00000335854.4 ENST00000455688.1 ENST00000330807.5 |
ALAS2
|
aminolevulinate, delta-, synthase 2 |
| chr7_-_142240014 | 5.60 |
ENST00000390363.2
|
TRBV9
|
T cell receptor beta variable 9 |
| chr7_-_38305279 | 5.60 |
ENST00000443402.2
|
TRGC1
|
T cell receptor gamma constant 1 |
| chr14_+_22615942 | 5.56 |
ENST00000390457.2
|
TRAV27
|
T cell receptor alpha variable 27 |
| chr7_-_38289173 | 5.53 |
ENST00000436911.2
|
TRGC2
|
T cell receptor gamma constant 2 |
| chr19_+_42381337 | 5.40 |
ENST00000597454.1
ENST00000444740.2 |
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
| chr2_+_90153696 | 5.40 |
ENST00000417279.2
|
IGKV3D-15
|
immunoglobulin kappa variable 3D-15 (gene/pseudogene) |
| chr4_-_71532207 | 5.39 |
ENST00000543780.1
ENST00000391614.3 |
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
| chr2_+_90024732 | 5.37 |
ENST00000390268.2
|
IGKV2D-26
|
immunoglobulin kappa variable 2D-26 |
| chr14_+_22409308 | 5.35 |
ENST00000390441.2
|
TRAV9-2
|
T cell receptor alpha variable 9-2 |
| chr16_+_30484054 | 5.35 |
ENST00000564118.1
ENST00000454514.2 ENST00000433423.2 |
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
| chr11_+_60163775 | 5.33 |
ENST00000300187.6
ENST00000395005.2 |
MS4A14
|
membrane-spanning 4-domains, subfamily A, member 14 |
| chr2_-_89442621 | 5.30 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
| chr2_+_90211643 | 5.26 |
ENST00000390277.2
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11 |
| chr18_+_61554932 | 5.25 |
ENST00000299502.4
ENST00000457692.1 ENST00000413956.1 |
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
| chr17_-_37934466 | 5.24 |
ENST00000583368.1
|
IKZF3
|
IKAROS family zinc finger 3 (Aiolos) |
| chr6_-_24799117 | 5.21 |
ENST00000565469.1
|
RP3-369A17.5
|
chromosome 6 open reading frame 229 |
| chr14_-_106453155 | 5.21 |
ENST00000390594.2
|
IGHV1-2
|
immunoglobulin heavy variable 1-2 |
| chr11_-_104972158 | 5.05 |
ENST00000598974.1
ENST00000593315.1 ENST00000594519.1 ENST00000415981.2 ENST00000525374.1 ENST00000375707.1 |
CASP1
CARD16
CARD17
|
caspase 1, apoptosis-related cysteine peptidase caspase recruitment domain family, member 16 caspase recruitment domain family, member 17 |
| chr7_-_142247606 | 5.04 |
ENST00000390361.3
|
TRBV7-3
|
T cell receptor beta variable 7-3 |
| chr8_-_57472049 | 5.01 |
ENST00000523786.1
ENST00000521483.1 |
LINC00968
|
long intergenic non-protein coding RNA 968 |
| chr1_+_153175900 | 5.01 |
ENST00000368747.1
|
LELP1
|
late cornified envelope-like proline-rich 1 |
| chr2_+_90273679 | 5.00 |
ENST00000423080.2
|
IGKV3D-7
|
immunoglobulin kappa variable 3D-7 |
| chr4_-_48082192 | 4.96 |
ENST00000507351.1
|
TXK
|
TXK tyrosine kinase |
| chr14_-_106733624 | 4.94 |
ENST00000390610.2
|
IGHV1-24
|
immunoglobulin heavy variable 1-24 |
| chr4_-_25865159 | 4.91 |
ENST00000502949.1
ENST00000264868.5 ENST00000513691.1 ENST00000514872.1 |
SEL1L3
|
sel-1 suppressor of lin-12-like 3 (C. elegans) |
| chr12_-_9760482 | 4.87 |
ENST00000229402.3
|
KLRB1
|
killer cell lectin-like receptor subfamily B, member 1 |
| chr5_+_156607829 | 4.87 |
ENST00000422843.3
|
ITK
|
IL2-inducible T-cell kinase |
| chr7_-_142162390 | 4.82 |
ENST00000390371.3
|
TRBV6-6
|
T cell receptor beta variable 6-6 |
| chr7_+_142448053 | 4.82 |
ENST00000422143.2
|
TRBV29-1
|
T cell receptor beta variable 29-1 |
| chr22_+_23264766 | 4.81 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
| chr15_+_58430567 | 4.78 |
ENST00000536493.1
|
AQP9
|
aquaporin 9 |
| chr2_-_219031709 | 4.77 |
ENST00000295683.2
|
CXCR1
|
chemokine (C-X-C motif) receptor 1 |
| chr8_-_57472154 | 4.76 |
ENST00000499425.1
ENST00000523664.1 ENST00000518943.1 ENST00000524338.1 |
LINC00968
|
long intergenic non-protein coding RNA 968 |
| chr2_-_89160425 | 4.74 |
ENST00000390239.2
|
IGKJ4
|
immunoglobulin kappa joining 4 |
| chr1_+_160709076 | 4.72 |
ENST00000359331.4
ENST00000495334.1 |
SLAMF7
|
SLAM family member 7 |
| chr2_-_89459813 | 4.68 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
| chr9_+_13446472 | 4.67 |
ENST00000428006.2
|
RP11-536O18.1
|
RP11-536O18.1 |
| chr3_-_112218378 | 4.66 |
ENST00000334529.5
|
BTLA
|
B and T lymphocyte associated |
| chr19_-_7764281 | 4.65 |
ENST00000360067.4
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23) |
| chr1_-_157670647 | 4.64 |
ENST00000368184.3
|
FCRL3
|
Fc receptor-like 3 |
| chr2_-_89385283 | 4.55 |
ENST00000390252.2
|
IGKV3-15
|
immunoglobulin kappa variable 3-15 |
| chr9_+_135854091 | 4.52 |
ENST00000450530.1
ENST00000534944.1 |
GFI1B
|
growth factor independent 1B transcription repressor |
| chr22_+_23247030 | 4.51 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
| chr14_-_106725723 | 4.51 |
ENST00000390609.2
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
| chr11_+_60102304 | 4.51 |
ENST00000300182.4
|
MS4A6E
|
membrane-spanning 4-domains, subfamily A, member 6E |
| chr14_+_22694606 | 4.49 |
ENST00000390463.3
|
TRAV36DV7
|
T cell receptor alpha variable 36/delta variable 7 |
| chr17_-_38721711 | 4.47 |
ENST00000578085.1
ENST00000246657.2 |
CCR7
|
chemokine (C-C motif) receptor 7 |
| chr8_-_21771182 | 4.44 |
ENST00000523932.1
ENST00000544659.1 |
DOK2
|
docking protein 2, 56kDa |
| chr7_+_80275621 | 4.40 |
ENST00000426978.1
ENST00000432207.1 |
CD36
|
CD36 molecule (thrombospondin receptor) |
| chr3_+_46412345 | 4.40 |
ENST00000292303.4
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene) |
| chr3_-_112218205 | 4.39 |
ENST00000383680.4
|
BTLA
|
B and T lymphocyte associated |
| chr2_+_89196746 | 4.39 |
ENST00000390244.2
|
IGKV5-2
|
immunoglobulin kappa variable 5-2 |
| chr12_+_75874580 | 4.38 |
ENST00000456650.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
| chr1_-_28503693 | 4.38 |
ENST00000373857.3
|
PTAFR
|
platelet-activating factor receptor |
| chr11_-_104905840 | 4.37 |
ENST00000526568.1
ENST00000393136.4 ENST00000531166.1 ENST00000534497.1 ENST00000527979.1 ENST00000446369.1 ENST00000353247.5 ENST00000528974.1 ENST00000533400.1 ENST00000525825.1 ENST00000436863.3 |
CASP1
|
caspase 1, apoptosis-related cysteine peptidase |
| chr14_-_106539557 | 4.36 |
ENST00000390599.2
|
IGHV1-8
|
immunoglobulin heavy variable 1-8 |
| chr19_+_49838653 | 4.36 |
ENST00000598095.1
ENST00000426897.2 ENST00000323906.4 ENST00000535669.2 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
| chrX_-_70331298 | 4.35 |
ENST00000456850.2
ENST00000473378.1 ENST00000487883.1 ENST00000374202.2 |
IL2RG
|
interleukin 2 receptor, gamma |
| chr14_+_22089953 | 4.35 |
ENST00000542354.1
|
TRAV1-1
|
T cell receptor alpha variable 1-1 |
| chr14_-_106518922 | 4.34 |
ENST00000390598.2
|
IGHV3-7
|
immunoglobulin heavy variable 3-7 |
| chr6_-_133079022 | 4.29 |
ENST00000525289.1
ENST00000326499.6 |
VNN2
|
vanin 2 |
| chr14_+_22386325 | 4.27 |
ENST00000390439.2
|
TRAV13-2
|
T cell receptor alpha variable 13-2 |
| chr1_-_179457805 | 4.25 |
ENST00000600581.1
|
AL160286.1
|
Uncharacterized protein |
| chr2_-_89161432 | 4.23 |
ENST00000390242.2
|
IGKJ1
|
immunoglobulin kappa joining 1 |
| chr22_+_23161491 | 4.23 |
ENST00000390316.2
|
IGLV3-9
|
immunoglobulin lambda variable 3-9 (gene/pseudogene) |
| chr20_-_1638408 | 4.22 |
ENST00000303415.3
ENST00000381583.2 |
SIRPG
|
signal-regulatory protein gamma |
| chr2_-_89513402 | 4.21 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
| chr3_-_27764190 | 4.20 |
ENST00000537516.1
|
EOMES
|
eomesodermin |
| chr2_-_89327228 | 4.20 |
ENST00000483158.1
|
IGKV3-11
|
immunoglobulin kappa variable 3-11 |
| chr14_-_107199464 | 4.19 |
ENST00000433072.2
|
IGHV3-72
|
immunoglobulin heavy variable 3-72 |
| chr8_-_21771214 | 4.17 |
ENST00000276420.4
|
DOK2
|
docking protein 2, 56kDa |
| chr5_-_156390230 | 4.16 |
ENST00000407087.3
ENST00000274532.2 |
TIMD4
|
T-cell immunoglobulin and mucin domain containing 4 |
| chr19_-_54784937 | 4.11 |
ENST00000434421.1
ENST00000314446.5 ENST00000391749.4 |
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 |
| chr16_+_28943260 | 4.10 |
ENST00000538922.1
ENST00000324662.3 ENST00000567541.1 |
CD19
|
CD19 molecule |
| chr20_-_1638360 | 4.10 |
ENST00000216927.4
ENST00000344103.4 |
SIRPG
|
signal-regulatory protein gamma |
| chr1_-_157670528 | 4.07 |
ENST00000368186.5
ENST00000496769.1 |
FCRL3
|
Fc receptor-like 3 |
| chr9_-_137809718 | 4.06 |
ENST00000371806.3
|
FCN1
|
ficolin (collagen/fibrinogen domain containing) 1 |
| chr6_+_26383318 | 4.06 |
ENST00000469230.1
ENST00000490025.1 ENST00000356709.4 ENST00000352867.2 ENST00000493275.1 ENST00000472507.1 ENST00000482536.1 ENST00000432533.2 ENST00000482842.1 |
BTN2A2
|
butyrophilin, subfamily 2, member A2 |
| chr12_+_9980069 | 4.04 |
ENST00000354855.3
ENST00000324214.4 ENST00000279544.3 |
KLRF1
|
killer cell lectin-like receptor subfamily F, member 1 |
| chr14_+_22217447 | 4.03 |
ENST00000390427.3
|
TRAV5
|
T cell receptor alpha variable 5 |
| chr22_+_23241661 | 4.01 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
| chr5_+_54320078 | 3.99 |
ENST00000231009.2
|
GZMK
|
granzyme K (granzyme 3; tryptase II) |
| chr6_+_31674639 | 3.98 |
ENST00000556581.1
ENST00000375832.4 ENST00000503322.1 |
LY6G6F
MEGT1
|
lymphocyte antigen 6 complex, locus G6F HCG43720, isoform CRA_a; Lymphocyte antigen 6 complex locus protein G6f; Megakaryocyte-enhanced gene transcript 1 protein; Uncharacterized protein |
| chr9_+_75766763 | 3.94 |
ENST00000456643.1
ENST00000415424.1 |
ANXA1
|
annexin A1 |
| chr1_-_159046617 | 3.91 |
ENST00000368130.4
|
AIM2
|
absent in melanoma 2 |
| chr19_+_7710774 | 3.90 |
ENST00000602355.1
|
STXBP2
|
syntaxin binding protein 2 |
| chr6_-_32731243 | 3.89 |
ENST00000427449.1
ENST00000411527.1 |
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2 |
| chr22_+_40322595 | 3.89 |
ENST00000420971.1
ENST00000544756.1 |
GRAP2
|
GRB2-related adaptor protein 2 |
| chr7_-_142149390 | 3.88 |
ENST00000390372.3
|
TRBV5-5
|
T cell receptor beta variable 5-5 |
| chr14_-_106471723 | 3.86 |
ENST00000390595.2
|
IGHV1-3
|
immunoglobulin heavy variable 1-3 |
| chr2_+_152214098 | 3.86 |
ENST00000243347.3
|
TNFAIP6
|
tumor necrosis factor, alpha-induced protein 6 |
| chr4_+_40194570 | 3.85 |
ENST00000507851.1
|
RHOH
|
ras homolog family member H |
| chr13_-_46756351 | 3.84 |
ENST00000323076.2
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
| chr1_-_167059830 | 3.84 |
ENST00000367868.3
|
GPA33
|
glycoprotein A33 (transmembrane) |
| chr16_+_85936295 | 3.84 |
ENST00000563180.1
ENST00000564617.1 ENST00000564803.1 |
IRF8
|
interferon regulatory factor 8 |
| chr7_+_142028105 | 3.83 |
ENST00000390353.2
|
TRBV6-1
|
T cell receptor beta variable 6-1 |
| chr14_-_107114267 | 3.83 |
ENST00000454421.2
|
IGHV3-64
|
immunoglobulin heavy variable 3-64 |
| chr11_-_118095718 | 3.82 |
ENST00000526620.1
|
AMICA1
|
adhesion molecule, interacts with CXADR antigen 1 |
| chr2_+_90077680 | 3.81 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
| chr11_+_65647280 | 3.79 |
ENST00000307886.3
ENST00000528419.1 ENST00000526034.1 |
CTSW
|
cathepsin W |
| chr7_+_80275953 | 3.79 |
ENST00000538969.1
ENST00000544133.1 ENST00000433696.2 |
CD36
|
CD36 molecule (thrombospondin receptor) |
| chr1_+_160765919 | 3.78 |
ENST00000341032.4
ENST00000368041.2 ENST00000368040.1 |
LY9
|
lymphocyte antigen 9 |
| chr7_+_142364193 | 3.77 |
ENST00000390397.2
|
TRBV24-1
|
T cell receptor beta variable 24-1 |
| chr3_+_108541608 | 3.77 |
ENST00000426646.1
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1 |
| chr1_+_160709029 | 3.73 |
ENST00000444090.2
ENST00000441662.2 |
SLAMF7
|
SLAM family member 7 |
| chr2_+_90043607 | 3.73 |
ENST00000462693.1
|
IGKV2D-24
|
immunoglobulin kappa variable 2D-24 (non-functional) |
| chr5_+_118691008 | 3.73 |
ENST00000504642.1
|
TNFAIP8
|
tumor necrosis factor, alpha-induced protein 8 |
| chr2_-_89545079 | 3.71 |
ENST00000468494.1
|
IGKV2-30
|
immunoglobulin kappa variable 2-30 |
| chr12_-_10022735 | 3.70 |
ENST00000228438.2
|
CLEC2B
|
C-type lectin domain family 2, member B |
| chr2_+_204801471 | 3.69 |
ENST00000316386.6
ENST00000435193.1 |
ICOS
|
inducible T-cell co-stimulator |
| chr22_+_40322623 | 3.69 |
ENST00000399090.2
|
GRAP2
|
GRB2-related adaptor protein 2 |
| chr18_-_68317947 | 3.69 |
ENST00000594039.1
ENST00000582578.1 |
GTSCR1
|
Gilles de la Tourette syndrome chromosome region, candidate 1 |
| chr14_-_106878083 | 3.68 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
| chr1_+_198608146 | 3.67 |
ENST00000367376.2
ENST00000352140.3 ENST00000594404.1 ENST00000598951.1 ENST00000530727.1 ENST00000442510.2 ENST00000367367.4 ENST00000348564.6 ENST00000367364.1 ENST00000413409.2 |
PTPRC
|
protein tyrosine phosphatase, receptor type, C |
| chr2_-_158345462 | 3.64 |
ENST00000439355.1
ENST00000540637.1 |
CYTIP
|
cytohesin 1 interacting protein |
| chr4_-_71532339 | 3.63 |
ENST00000254801.4
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
| chr14_+_22392209 | 3.62 |
ENST00000390440.2
|
TRAV14DV4
|
T cell receptor alpha variable 14/delta variable 4 |
| chr14_-_106830057 | 3.62 |
ENST00000390616.2
|
IGHV4-34
|
immunoglobulin heavy variable 4-34 |
| chr11_-_118213360 | 3.62 |
ENST00000529594.1
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex) |
| chr2_+_204571198 | 3.61 |
ENST00000374481.3
ENST00000458610.2 ENST00000324106.8 |
CD28
|
CD28 molecule |
| chr10_-_14646388 | 3.59 |
ENST00000468747.1
ENST00000378467.4 |
FAM107B
|
family with sequence similarity 107, member B |
| chr3_+_114012819 | 3.59 |
ENST00000383671.3
|
TIGIT
|
T cell immunoreceptor with Ig and ITIM domains |
| chr6_-_31550192 | 3.57 |
ENST00000429299.2
ENST00000446745.2 |
LTB
|
lymphotoxin beta (TNF superfamily, member 3) |
| chr14_-_106692191 | 3.56 |
ENST00000390607.2
|
IGHV3-21
|
immunoglobulin heavy variable 3-21 |
| chr22_+_22516550 | 3.56 |
ENST00000390284.2
|
IGLV4-60
|
immunoglobulin lambda variable 4-60 |
| chr5_+_118690466 | 3.55 |
ENST00000503646.1
|
TNFAIP8
|
tumor necrosis factor, alpha-induced protein 8 |
| chr12_+_8666126 | 3.54 |
ENST00000299665.2
|
CLEC4D
|
C-type lectin domain family 4, member D |
| chr1_+_161677034 | 3.53 |
ENST00000349527.4
ENST00000309691.6 ENST00000294796.4 ENST00000367953.3 ENST00000367950.1 |
FCRLA
|
Fc receptor-like A |
| chr3_+_108541545 | 3.53 |
ENST00000295756.6
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1 |
| chr2_-_158300556 | 3.52 |
ENST00000264192.3
|
CYTIP
|
cytohesin 1 interacting protein |
| chr21_+_10862622 | 3.50 |
ENST00000302092.5
ENST00000559480.1 |
IGHV1OR21-1
|
immunoglobulin heavy variable 1/OR21-1 (non-functional) |
| chr3_-_46506563 | 3.50 |
ENST00000231751.4
|
LTF
|
lactotransferrin |
| chr11_+_118175132 | 3.50 |
ENST00000361763.4
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex) |
| chr7_-_36764004 | 3.50 |
ENST00000431169.1
|
AOAH
|
acyloxyacyl hydrolase (neutrophil) |
| chr20_-_56195449 | 3.49 |
ENST00000541799.1
|
ZBP1
|
Z-DNA binding protein 1 |
| chr4_+_68424434 | 3.49 |
ENST00000265404.2
ENST00000396225.1 |
STAP1
|
signal transducing adaptor family member 1 |
| chr11_-_118095801 | 3.48 |
ENST00000356289.5
|
AMICA1
|
adhesion molecule, interacts with CXADR antigen 1 |
| chr1_-_157522260 | 3.47 |
ENST00000368191.3
ENST00000361835.3 |
FCRL5
|
Fc receptor-like 5 |
| chr8_-_126963487 | 3.47 |
ENST00000518964.1
|
LINC00861
|
long intergenic non-protein coding RNA 861 |
| chr22_+_22786288 | 3.46 |
ENST00000390301.2
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
| chr1_-_153518270 | 3.46 |
ENST00000354332.4
ENST00000368716.4 |
S100A4
|
S100 calcium binding protein A4 |
| chr6_+_26383404 | 3.45 |
ENST00000416795.2
ENST00000494184.1 |
BTN2A2
|
butyrophilin, subfamily 2, member A2 |
| chr2_+_231090471 | 3.42 |
ENST00000373645.3
|
SP140
|
SP140 nuclear body protein |
| chr14_+_22554680 | 3.42 |
ENST00000390451.2
|
TRAV23DV6
|
T cell receptor alpha variable 23/delta variable 6 |
| chr1_+_167599330 | 3.40 |
ENST00000367854.3
ENST00000361496.3 |
RCSD1
|
RCSD domain containing 1 |
| chr22_+_23029188 | 3.39 |
ENST00000390305.2
|
IGLV3-25
|
immunoglobulin lambda variable 3-25 |
| chr7_+_142020496 | 3.39 |
ENST00000390381.3
|
TRBV5-1
|
T cell receptor beta variable 5-1 |
| chr6_-_32784687 | 3.39 |
ENST00000447394.1
ENST00000438763.2 |
HLA-DOB
|
major histocompatibility complex, class II, DO beta |
| chr12_+_47610315 | 3.38 |
ENST00000548348.1
ENST00000549500.1 |
PCED1B
|
PC-esterase domain containing 1B |
| chr19_+_7828035 | 3.38 |
ENST00000327325.5
ENST00000394122.2 ENST00000248228.4 ENST00000334806.5 ENST00000359059.5 ENST00000357361.2 ENST00000596363.1 ENST00000595751.1 ENST00000596707.1 ENST00000597522.1 ENST00000595496.1 |
CLEC4M
|
C-type lectin domain family 4, member M |
| chr1_+_209929494 | 3.37 |
ENST00000367026.3
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
Network of associatons between targets according to the STRING database.
First level regulatory network of FOXM1_TBL1XR1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.7 | 22.0 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 3.5 | 3.5 | GO:1903973 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
| 3.4 | 13.7 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 2.9 | 8.7 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 2.7 | 16.1 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
| 2.6 | 7.9 | GO:0033212 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
| 2.6 | 7.7 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 2.5 | 7.6 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
| 2.4 | 7.1 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 2.3 | 25.4 | GO:2000332 | blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
| 2.3 | 9.1 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 2.2 | 6.5 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
| 2.2 | 6.5 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
| 2.1 | 17.1 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 2.1 | 25.0 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
| 2.1 | 10.4 | GO:2000473 | regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
| 2.0 | 12.2 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 2.0 | 23.4 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 1.9 | 11.7 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
| 1.9 | 5.7 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 1.8 | 5.5 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 1.8 | 14.8 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 1.8 | 5.5 | GO:0072616 | interleukin-18 secretion(GO:0072616) |
| 1.8 | 5.3 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
| 1.7 | 6.8 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 1.7 | 5.0 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 1.7 | 1.7 | GO:0071613 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
| 1.7 | 1.7 | GO:0033227 | dsRNA transport(GO:0033227) |
| 1.7 | 1.7 | GO:0034125 | negative regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034125) regulation of interleukin-4-mediated signaling pathway(GO:1902214) |
| 1.6 | 22.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 1.6 | 111.9 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 1.6 | 4.7 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
| 1.5 | 1.5 | GO:0001781 | neutrophil apoptotic process(GO:0001781) |
| 1.5 | 4.4 | GO:0052331 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 1.5 | 4.4 | GO:1902565 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 1.4 | 8.5 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
| 1.4 | 7.0 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 1.4 | 4.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 1.4 | 12.4 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 1.3 | 8.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 1.3 | 5.4 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 1.3 | 4.0 | GO:0021569 | rhombomere 3 development(GO:0021569) |
| 1.3 | 1.3 | GO:0090265 | positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) |
| 1.3 | 5.3 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 1.3 | 6.6 | GO:0039650 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
| 1.3 | 5.1 | GO:0052362 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
| 1.3 | 6.4 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
| 1.3 | 2.5 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
| 1.3 | 3.8 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
| 1.2 | 146.6 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 1.2 | 6.1 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 1.2 | 1.2 | GO:0002856 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
| 1.2 | 6.0 | GO:1904073 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
| 1.2 | 1.2 | GO:0035700 | astrocyte chemotaxis(GO:0035700) regulation of astrocyte chemotaxis(GO:2000458) |
| 1.1 | 5.7 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 1.1 | 5.7 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 1.1 | 4.5 | GO:0070340 | detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
| 1.1 | 5.6 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 1.1 | 5.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
| 1.1 | 10.0 | GO:0070269 | pyroptosis(GO:0070269) |
| 1.0 | 1.0 | GO:0035566 | regulation of metanephros size(GO:0035566) |
| 1.0 | 2.0 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 1.0 | 6.8 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
| 1.0 | 4.9 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 1.0 | 4.8 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 1.0 | 3.8 | GO:0032416 | negative regulation of sodium:proton antiporter activity(GO:0032416) |
| 0.9 | 5.7 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
| 0.9 | 1.9 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.9 | 6.6 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
| 0.9 | 11.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 0.9 | 1.8 | GO:0001794 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) |
| 0.9 | 2.7 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.9 | 0.9 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
| 0.9 | 2.7 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.9 | 0.9 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 0.9 | 21.1 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
| 0.9 | 6.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 0.9 | 3.5 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
| 0.9 | 3.5 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.9 | 1.7 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
| 0.9 | 1.7 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
| 0.9 | 5.2 | GO:2000683 | regulation of cellular response to X-ray(GO:2000683) |
| 0.9 | 0.9 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
| 0.8 | 2.5 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
| 0.8 | 3.3 | GO:2000173 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.8 | 2.5 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.8 | 7.4 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.8 | 2.5 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.8 | 3.3 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
| 0.8 | 6.5 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) |
| 0.8 | 2.5 | GO:2000427 | positive regulation of engulfment of apoptotic cell(GO:1901076) positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.8 | 11.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.8 | 0.8 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.8 | 3.2 | GO:0018277 | protein deamination(GO:0018277) |
| 0.8 | 166.6 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.8 | 9.6 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.8 | 5.6 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.8 | 14.3 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.8 | 1.6 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
| 0.8 | 2.4 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.8 | 2.4 | GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
| 0.8 | 5.5 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.8 | 3.1 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.8 | 0.8 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) |
| 0.8 | 0.8 | GO:0033594 | response to hydroxyisoflavone(GO:0033594) |
| 0.8 | 2.3 | GO:0033037 | polysaccharide localization(GO:0033037) |
| 0.8 | 2.3 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.8 | 2.3 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
| 0.8 | 6.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.8 | 2.3 | GO:0002818 | intracellular defense response(GO:0002818) |
| 0.8 | 7.5 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.8 | 1.5 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
| 0.7 | 2.2 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
| 0.7 | 5.9 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.7 | 3.7 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.7 | 5.1 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) |
| 0.7 | 1.5 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.7 | 3.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.7 | 0.7 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.7 | 1.4 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.7 | 2.2 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.7 | 2.2 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.7 | 1.4 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.7 | 3.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.7 | 9.9 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.7 | 2.1 | GO:0032730 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
| 0.7 | 15.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.7 | 0.7 | GO:0033189 | response to vitamin A(GO:0033189) |
| 0.7 | 1.4 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.7 | 2.8 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 0.7 | 4.8 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.7 | 3.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.7 | 1.4 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 0.7 | 6.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.7 | 2.0 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.7 | 6.7 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.7 | 8.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.7 | 1.3 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.7 | 21.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
| 0.7 | 9.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.7 | 5.9 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.7 | 10.5 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.7 | 2.0 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
| 0.7 | 1.3 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.7 | 1.3 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
| 0.6 | 1.3 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
| 0.6 | 3.2 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.6 | 1.9 | GO:0032824 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
| 0.6 | 7.7 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.6 | 1.9 | GO:1902299 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.6 | 1.3 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
| 0.6 | 5.7 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.6 | 3.2 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 0.6 | 6.3 | GO:0071317 | cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.6 | 5.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.6 | 1.9 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.6 | 1.2 | GO:2000418 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
| 0.6 | 0.6 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
| 0.6 | 1.2 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
| 0.6 | 10.3 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.6 | 2.4 | GO:0019732 | antifungal humoral response(GO:0019732) |
| 0.6 | 3.6 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.6 | 1.2 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
| 0.6 | 0.6 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
| 0.6 | 1.8 | GO:0002360 | T cell lineage commitment(GO:0002360) |
| 0.6 | 8.4 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
| 0.6 | 5.3 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.6 | 1.8 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.6 | 1.8 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
| 0.6 | 4.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.6 | 2.3 | GO:0060032 | notochord regression(GO:0060032) |
| 0.6 | 1.7 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
| 0.6 | 1.7 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
| 0.6 | 0.6 | GO:0060559 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
| 0.6 | 2.2 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
| 0.5 | 2.2 | GO:0071504 | cellular response to heparin(GO:0071504) |
| 0.5 | 0.5 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
| 0.5 | 7.1 | GO:0001562 | response to protozoan(GO:0001562) |
| 0.5 | 4.4 | GO:0002517 | T cell tolerance induction(GO:0002517) |
| 0.5 | 1.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 0.5 | 2.1 | GO:0046061 | dATP catabolic process(GO:0046061) |
| 0.5 | 1.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
| 0.5 | 2.1 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 0.5 | 1.6 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
| 0.5 | 4.3 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.5 | 1.1 | GO:0051180 | vitamin transport(GO:0051180) |
| 0.5 | 7.3 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
| 0.5 | 2.1 | GO:0021816 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
| 0.5 | 4.7 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.5 | 1.5 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.5 | 2.1 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.5 | 4.1 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.5 | 7.5 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.5 | 1.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.5 | 1.5 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
| 0.5 | 12.3 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
| 0.5 | 7.8 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.5 | 3.9 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.5 | 1.5 | GO:0030185 | nitric oxide transport(GO:0030185) |
| 0.5 | 0.5 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
| 0.5 | 0.5 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.5 | 0.5 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.5 | 3.8 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.5 | 3.3 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.5 | 1.4 | GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) negative regulation of mitotic cell cycle DNA replication(GO:1903464) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.5 | 0.5 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.5 | 1.4 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.5 | 5.2 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
| 0.5 | 3.3 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
| 0.5 | 1.4 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.5 | 1.4 | GO:1901656 | glycoside transport(GO:1901656) |
| 0.5 | 6.1 | GO:0042723 | thiamine-containing compound metabolic process(GO:0042723) |
| 0.5 | 0.9 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.5 | 1.9 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 0.5 | 0.5 | GO:0034756 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
| 0.5 | 50.1 | GO:0031295 | T cell costimulation(GO:0031295) |
| 0.5 | 0.5 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
| 0.5 | 3.3 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.5 | 0.5 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
| 0.5 | 0.5 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
| 0.5 | 0.9 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.4 | 0.9 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.4 | 0.9 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
| 0.4 | 4.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.4 | 0.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.4 | 2.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.4 | 19.4 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
| 0.4 | 6.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.4 | 2.2 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.4 | 31.0 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.4 | 1.3 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
| 0.4 | 5.6 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
| 0.4 | 5.6 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
| 0.4 | 1.7 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.4 | 2.1 | GO:0021546 | rhombomere development(GO:0021546) |
| 0.4 | 1.7 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.4 | 0.4 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 0.4 | 0.4 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.4 | 1.7 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.4 | 5.5 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.4 | 3.0 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 0.4 | 1.7 | GO:0098743 | cell aggregation(GO:0098743) |
| 0.4 | 2.5 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
| 0.4 | 5.0 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.4 | 1.2 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 0.4 | 0.8 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
| 0.4 | 1.2 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 0.4 | 2.1 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
| 0.4 | 1.2 | GO:0060345 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) spleen trabecula formation(GO:0060345) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
| 0.4 | 1.2 | GO:1902173 | negative regulation of keratinocyte apoptotic process(GO:1902173) |
| 0.4 | 2.4 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.4 | 1.2 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.4 | 2.4 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.4 | 1.6 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
| 0.4 | 1.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.4 | 0.4 | GO:0003032 | detection of oxygen(GO:0003032) |
| 0.4 | 6.0 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.4 | 0.8 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 0.4 | 1.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.4 | 1.2 | GO:0048925 | lateral line system development(GO:0048925) |
| 0.4 | 5.6 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.4 | 2.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.4 | 1.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.4 | 1.2 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.4 | 3.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.4 | 2.3 | GO:0016574 | histone ubiquitination(GO:0016574) |
| 0.4 | 1.2 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 0.4 | 3.1 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
| 0.4 | 1.2 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.4 | 1.5 | GO:0035627 | ceramide transport(GO:0035627) |
| 0.4 | 1.5 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.4 | 1.1 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.4 | 0.4 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.4 | 17.6 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
| 0.4 | 0.4 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.4 | 1.1 | GO:1905133 | metaphase/anaphase transition of meiotic cell cycle(GO:0044785) regulation of metaphase/anaphase transition of meiotic cell cycle(GO:1902102) negative regulation of metaphase/anaphase transition of meiotic cell cycle(GO:1902103) regulation of meiotic chromosome separation(GO:1905132) negative regulation of meiotic chromosome separation(GO:1905133) |
| 0.4 | 3.8 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.4 | 30.4 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
| 0.4 | 1.9 | GO:1904835 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.4 | 6.1 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
| 0.4 | 1.5 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.4 | 0.4 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.4 | 1.5 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.4 | 0.8 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.4 | 0.4 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
| 0.4 | 1.5 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.4 | 0.4 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 0.4 | 0.7 | GO:0003192 | mitral valve formation(GO:0003192) |
| 0.4 | 1.9 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) |
| 0.4 | 3.7 | GO:0072678 | T cell migration(GO:0072678) |
| 0.4 | 8.1 | GO:0019835 | cytolysis(GO:0019835) |
| 0.4 | 1.1 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.4 | 2.6 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
| 0.4 | 10.2 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.4 | 0.7 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 0.4 | 1.8 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.4 | 1.4 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
| 0.4 | 1.8 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.4 | 10.4 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 0.4 | 1.1 | GO:0100009 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 0.4 | 1.1 | GO:0042303 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
| 0.4 | 1.1 | GO:0002507 | tolerance induction(GO:0002507) |
| 0.4 | 4.6 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.4 | 18.3 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
| 0.4 | 2.8 | GO:0008228 | opsonization(GO:0008228) |
| 0.3 | 4.2 | GO:0046449 | creatinine metabolic process(GO:0046449) |
| 0.3 | 2.4 | GO:0001554 | luteolysis(GO:0001554) |
| 0.3 | 1.7 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.3 | 1.4 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.3 | 1.0 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.3 | 2.4 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
| 0.3 | 2.8 | GO:0048625 | myoblast fate commitment(GO:0048625) |
| 0.3 | 3.1 | GO:0060751 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
| 0.3 | 2.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.3 | 0.7 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.3 | 0.7 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
| 0.3 | 1.0 | GO:0061743 | motor learning(GO:0061743) |
| 0.3 | 1.0 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.3 | 0.3 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
| 0.3 | 6.1 | GO:0010042 | response to manganese ion(GO:0010042) |
| 0.3 | 1.0 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.3 | 1.7 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.3 | 1.7 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.3 | 1.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.3 | 2.0 | GO:0070229 | negative regulation of lymphocyte apoptotic process(GO:0070229) negative regulation of T cell apoptotic process(GO:0070233) |
| 0.3 | 1.0 | GO:1903676 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
| 0.3 | 1.0 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
| 0.3 | 6.2 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
| 0.3 | 2.9 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.3 | 1.0 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.3 | 0.3 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.3 | 1.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 0.3 | 1.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.3 | 0.3 | GO:0044241 | lipid digestion(GO:0044241) |
| 0.3 | 0.3 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
| 0.3 | 2.6 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.3 | 1.6 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
| 0.3 | 1.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.3 | 0.6 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
| 0.3 | 1.3 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
| 0.3 | 0.6 | GO:0036337 | Fas signaling pathway(GO:0036337) regulation of Fas signaling pathway(GO:1902044) |
| 0.3 | 2.8 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.3 | 0.6 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
| 0.3 | 0.3 | GO:0060038 | cardiac muscle cell proliferation(GO:0060038) |
| 0.3 | 1.3 | GO:0051413 | response to cortisone(GO:0051413) |
| 0.3 | 3.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.3 | 0.9 | GO:2001113 | negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
| 0.3 | 5.7 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.3 | 1.9 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.3 | 6.9 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.3 | 0.3 | GO:0031296 | B cell costimulation(GO:0031296) |
| 0.3 | 2.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.3 | 0.9 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.3 | 1.2 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.3 | 1.5 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.3 | 1.5 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
| 0.3 | 0.6 | GO:0016075 | rRNA catabolic process(GO:0016075) |
| 0.3 | 7.1 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.3 | 2.8 | GO:0002347 | response to tumor cell(GO:0002347) |
| 0.3 | 3.7 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.3 | 1.2 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.3 | 0.6 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
| 0.3 | 0.3 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 0.3 | 0.9 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
| 0.3 | 5.4 | GO:0001909 | leukocyte mediated cytotoxicity(GO:0001909) |
| 0.3 | 4.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
| 0.3 | 0.9 | GO:0007135 | meiosis II(GO:0007135) |
| 0.3 | 6.0 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.3 | 0.3 | GO:0009441 | glycolate metabolic process(GO:0009441) |
| 0.3 | 2.1 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.3 | 12.8 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.3 | 1.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.3 | 0.3 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.3 | 0.9 | GO:1901291 | negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
| 0.3 | 0.9 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.3 | 0.6 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.3 | 0.3 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.3 | 0.3 | GO:0060558 | regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
| 0.3 | 1.7 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.3 | 1.2 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.3 | 0.6 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 0.3 | 0.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.3 | 1.4 | GO:0048880 | sensory system development(GO:0048880) |
| 0.3 | 1.7 | GO:0010756 | regulation of plasminogen activation(GO:0010755) positive regulation of plasminogen activation(GO:0010756) |
| 0.3 | 45.0 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.3 | 0.9 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.3 | 1.7 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.3 | 6.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.3 | 0.6 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.3 | 1.4 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
| 0.3 | 0.8 | GO:0034127 | regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034127) |
| 0.3 | 0.6 | GO:0036102 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.3 | 1.7 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
| 0.3 | 0.3 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.3 | 3.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.3 | 2.0 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.3 | 0.8 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.3 | 0.6 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.3 | 9.5 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
| 0.3 | 0.3 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
| 0.3 | 0.8 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.3 | 1.7 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 0.3 | 1.1 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.3 | 0.8 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.3 | 0.3 | GO:0016233 | telomere capping(GO:0016233) |
| 0.3 | 1.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.3 | 0.5 |